Acrivon Therapeutics
ACRV
ACRV
53 hedge funds and large institutions have $21.2M invested in Acrivon Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less capital invested
Capital invested by funds: $45.7M → $21.2M (-$24.5M)
Holders
53
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$544K | |
| 2 | +$455K | |
| 3 | +$371K | |
| 4 |
Millennium Management
New York
|
+$353K |
| 5 |
Two Sigma Investments
New York
|
+$216K |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$632K | |
| 3 | -$320K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$197K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$169K |
